Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05724992 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Familial Pancreatic Cancer PROPHilation Program in Italy

Study acronym: PROPH-ITA
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Secondary endpoints: 1 to 2v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of the PROPH-ITA Study is to perform genetic testing in family members of pancreatic cancer patients who may have a genetic predisposition. The subjects belong to the Italian Registry of Families At Risk of Pancreatic Cancer (IRFARPC, #NCT04095195). This investigational study will assess the genetic background of subjects with familiarity with pancreatic cancer only. Participants may accept to undergo genetic testing as part of the IRFARPC registry, through a saliva-swab-based 41-gene panel test. Up to 3,000 participants will be enrolled in this study.
Trial Details
NCT Number NCT05724992
Lead Sponsor Associazione Italiana per lo Studio del Pancreas
Collaborators: General and Pancreatic Surgery Unit, University of Verona, Fondazione Valsecchi, Associazione Oltre La Ricerca, Genomica srl
Conditions
(from sponsor)		 Candidates for Hereditary Pancreatic Cancer Testing
Related terms Genetic Predisposition to Disease, Pancreatic Neoplasms
Enrollment 3,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov